K. Rantakokko et al., ANTIBODIES TO STREPTOCOCCAL CELL-WALL IN PSORIATIC-ARTHRITIS AND CUTANEOUS PSORIASIS, Clinical and experimental rheumatology, 15(4), 1997, pp. 399-404
Objective, To evaluate the possible role of streptococcal cell wall an
tigens in the development of psoriatic arthritis. Methods. IgM, IgA an
d IgG class serum antibodies against peptidoglycan-polysaccharide (PG-
PS) and peptidoglycan (PG), both front group A streptococcus, were mea
sured in patients with psoriatic arthritis (PA), non-arthritic psorias
is (NAP), rheumatoid arthritis (RA) and in healthy controls, using ELI
SA. Results. Both groups of psoriatic patients had elevated IgA levels
specific to streptococcal PG-PS. No association with the severity of
the skirt disease or with the different subsets of PA was detected Hig
her concentrations of IgG against the two streptococcal preparations w
as observed in PA than in RA. Analysis of antibody levels in patients
with recent onset arthritis showed lower concentrations of IgM antibod
ies against streptococcal as well as control antigens in early than in
late PA, whereas an overall increase of specific IgA and IgG antibodi
es was observed in early RA. Conclusion. The results suggest chronic m
ucosal stimulation of lymphocytes by long-lived streptococcal antigens
in patients with psoriasis, without any difference observed between P
A and NAP. The differences between recent onset versus established PA
and RA could reflect a distinct immunopathology in the two arthritides
.